Anti-EPHB2/ CAPB/ DRT monoclonal antibody

Anti-EPHB2/ CAPB/ DRT antibody for FACS & in-vivo assay

Target products collectionGo to EPHB2/EPHB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T73756-Ab-1/ GM-Tg-hg-T73756-Ab-2Anti-Human EPHB2 monoclonal antibodyHuman
GM-Tg-rg-T73756-Ab-1/ GM-Tg-rg-T73756-Ab-2Anti-Rat EPHB2 monoclonal antibodyRat
GM-Tg-mg-T73756-Ab-1/ GM-Tg-mg-T73756-Ab-2Anti-Mouse EPHB2 monoclonal antibodyMouse
GM-Tg-cynog-T73756-Ab-1/ GM-Tg-cynog-T73756-Ab-2Anti-Cynomolgus/ Rhesus macaque EPHB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T73756-Ab-1/ GM-Tg-felg-T73756-Ab-2Anti-Feline EPHB2 monoclonal antibodyFeline
GM-Tg-cang-T73756-Ab-1/ GM-Tg-cang-T73756-Ab-2Anti-Canine EPHB2 monoclonal antibodyCanine
GM-Tg-bovg-T73756-Ab-1/ GM-Tg-bovg-T73756-Ab-2Anti-Bovine EPHB2 monoclonal antibodyBovine
GM-Tg-equg-T73756-Ab-1/ GM-Tg-equg-T73756-Ab-2Anti-Equine EPHB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T73756-Ab-1/ GM-Tg-hg-T73756-Ab-2; GM-Tg-rg-T73756-Ab-1/ GM-Tg-rg-T73756-Ab-2;
GM-Tg-mg-T73756-Ab-1/ GM-Tg-mg-T73756-Ab-2; GM-Tg-cynog-T73756-Ab-1/ GM-Tg-cynog-T73756-Ab-2;
GM-Tg-felg-T73756-Ab-1/ GM-Tg-felg-T73756-Ab-2; GM-Tg-cang-T73756-Ab-1/ GM-Tg-cang-T73756-Ab-2;
GM-Tg-bovg-T73756-Ab-1/ GM-Tg-bovg-T73756-Ab-2; GM-Tg-equg-T73756-Ab-1/ GM-Tg-equg-T73756-Ab-2
Products NameAnti-EPHB2 monoclonal antibody
Formatmab
Target NameEPHB2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EPHB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species EPHB2/ CAPB/ DRT VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T73756
    Target NameEPHB2
    Gene ID2048,13844,313633,718570,487380,101095030,535137,100071661
    Gene Symbol and SynonymsBDPLT22,CAPB,Cek5,DRT,EK5,EPHB2,EPHT3,ERK,ETECK,Hek5,Nuk,PCBC,Prkm5,Qek5,RGD1564232,Sek3,Tyro5
    Uniprot AccessionP29323
    Uniprot Entry NameEPHB2_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000133216
    Target ClassificationTumor-associated antigen (TAA)

    The target: EPHB2, gene name: EPHB2, also named as CAPB, DRT, EK5, EPHT3, ERK, Hek5, PCBC, Tyro5. This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.